Literature DB >> 31857703

Blocking PD-L1 for anti-liver cancer immunity: USP22 represents a critical cotarget.

Xing Huang1,2,3, Xiaozhen Zhang1,2,3, Xueli Bai4,5,6, Tingbo Liang1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31857703      PMCID： PMC7331717          DOI： 10.1038/s41423-019-0348-4

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  8 in total

1.  The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.

Authors:  Yu Wang; Qingguo Sun; Ning Mu; Xiaoyang Sun; Yingying Wang; Songqing Fan; Ling Su; Xiangguo Liu
Journal:  Cell Commun Signal       Date:  2020-07-14       Impact factor: 5.712

2.  LncRNA KCNQ1OT1 Secreted by Tumor Cell-Derived Exosomes Mediates Immune Escape in Colorectal Cancer by Regulating PD-L1 Ubiquitination via MiR-30a-5p/USP22.

Authors:  Di Xian; Liangbo Niu; Jie Zeng; Lei Wang
Journal:  Front Cell Dev Biol       Date:  2021-07-19

3.  Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer.

Authors:  Yi-Bo He; Lu-Wei Fang; Dan Hu; Shi-Liang Chen; Si-Yu Shen; Kai-Li Chen; Jie Mu; Jun-Yu Li; Hongpan Zhang; Liu Yong-Lin; Li Zhang
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

Review 4.  Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.

Authors:  Jinhui Guo; Jie Zhao; Wen Fu; Qiuran Xu; Dongsheng Huang
Journal:  Front Immunol       Date:  2022-07-20       Impact factor: 8.786

Review 5.  Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment.

Authors:  Haiqiang Wang; Fan Shi; Shudan Zheng; Mei Zhao; Zimeng Pan; Li Xiong; Lihong Zheng
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

Review 6.  Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy.

Authors:  Xiaoli Hu; Jing Wang; Man Chu; Yi Liu; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Mol Ther       Date:  2021-01-01       Impact factor: 11.454

7.  Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.

Authors:  Yangyang Li; Yu Zhang; Guoshuai Cao; Xiaodong Zheng; Cheng Sun; Haiming Wei; Zhigang Tian; Weihua Xiao; Rui Sun; Haoyu Sun
Journal:  J Hematol Oncol       Date:  2021-06-26       Impact factor: 17.388

Review 8.  Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Authors:  Jun-Nan Guo; Bai-Rong Xia; Shen-Hui Deng; Chang Yang; Ya-Nan Pi; Bin-Bin Cui; Wei-Lin Jin
Journal:  Front Cell Dev Biol       Date:  2021-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.